Hart Market Intelligence - Thursday, June 11

Date: Thursday, June 11, 2026

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

MARKET OVERVIEW
Futures are pointing higher across the board as markets attempt to bounce from a bruising five-day S&P 500 stretch that shaved off over 3%. The tone feels more like oversold relief than a regime shift — thin volume, geopolitical noise, and the looming SpaceX IPO debut tomorrow are keeping traders on their toes. The cash open will be the real test of whether dip-buyers have conviction or are just filling air pockets.

• SPY: $728.34 (+0.40%)
• QQQ: $699.25 (+0.80%)
• DIA: $502.98 (+0.55%)
• IWM: $283.83 (+0.63%)

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

🔥 KEY THEMES
• Relief Rally or Dead Cat? — After five straight down days, the S&P is attempting to bounce. Futures are green, but breadth and volume remain questionable. Let price prove itself before committing size.
• Oracle's Warning Shot — Strong Q4 numbers ($2.11 EPS, $19.2B revenue, $638B backlog) weren't enough. A light Q1 guide sent the stock down 6% after hours, proving AI names now need to beat, raise, and promise more — or get punished.
• SpaceX IPO Looms — Pricing confirmed at $135/share ($1.77T valuation). Trading begins tomorrow under ticker SPCX. $300B in order interest for a $75B raise. This could be a liquidity/sentiment inflection point — for better or worse.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

📈 MOMENTUM WATCHLIST

Bullish Watch:
• ASML — Musk discussing Terafab chip plant plans at the ASML event adds fresh demand narrative for advanced lithography. 28% EPS growth, 53% gross margins. High-confidence 3-4 month setup.
• LLY — FDA Ebglyss approval expands Lilly's pipeline beyond GLP-1. 89% revenue growth, 293% EPS trajectory. A proven multi-horizon compounder with a fresh catalyst.

Potential Breakouts:
• FTNT — The -7.2% weekly pullback pulled Fortinet back to just 3% above its 20-day SMA, offering a better entry into a company with 121% revenue growth and a new AI workload firewall launch.
• KO — Morgan Stanley's top beverage bet ahead of the FIFA World Cup. 95 fundamental score, but the 8.8% weekly rally means waiting for a pullback toward $82 makes sense.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

🎯 MARKET PULSE

Trend: Neutral-to-bearish short-term; attempting oversold bounce
Momentum: Mixed — tech leading, but conviction is thin
Volatility: Elevated — geopolitical premium keeping ranges wide
Overall bias: Cautiously constructive for the session; size down

Key Levels:
• SPY support: 720 / 715  |  resistance: 730 / 735
• QQQ support: 690 / 685  |  resistance: 700 / 705

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

🤖 HART QUANT SIGNAL

Zero-Signal Streak: Day 8

The Hart Quant model has produced no actionable trade setups for five consecutive sessions. Historically, this is rare — compressed edge regimes don't last. The read: the market is coiling. When the breakout comes, it may catch consensus offside. Patience is the position until the model flags an edge.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

💡 QUANT INSIGHT

Markets are pricing in two conflicting narratives simultaneously: AI infrastructure demand is structurally intact (Oracle's $638B backlog is real), while the bar for AI deployers has been raised to an impossible height. The quant read is simple — follow the capital, not the commentary. Builders (semicap, power, data center infrastructure) are seeing the money. Deployers (software, ad-tech) are seeing the scrutiny. That divergence is tradable.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

COMING NEXT

• Today: ECB rate decision (expected first hike in 3 years), US jobless claims (8:30 AM ET), Adobe (ADBE) earnings after the close — guide matters more than the headline beat.
• Tomorrow: May PPI, SpaceX (SPCX) begins trading. Watch whether the IPO acts as a liquidity magnet or a "sell the news" drain on the broader market.

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Hart Quantitative Research
Visit: https://hartquantitativeresearch.com

━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━

Disclaimer: This newsletter is for informational and educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always do your own research and consult with a qualified financial advisor before making investment decisions.